High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.

Documents similaires

• High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
  par: Liberante, F, et autres
  Publié: (2013)
• Overexpression of WT1 and PRAME predicts poor outcomes of patients with myelodysplastic syndromes with thrombocytopenia
  par: Qiu-Sha Huang, et autres
  Publié: (2019-11-01)
• Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
  par: Pellagatti, A, et autres
  Publié: (2010)
• Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
  par: Pellagatti, A, et autres
  Publié: (2010)
• SF3B1 mutant myelodysplastic syndrome: Recent advances
  par: Pellagatti, A, et autres
  Publié: (2020)